Association of CTLA-4 gene microsatellite polymorphism with ulcerative colitis in Chinese patients

Inflammatory Bowel Diseases

Volumn 12, Issue 5, 2006, Pages 369-373

  Jiang, Yi ^a   Xia, Bing ^a,c   Jiang, Li ^a   Lv, Min ^a   Guo, Qiusha ^a   Chen, Min ^a   Li, Jin ^a   Xia, Harry Hua Xiang ^b   Wong, Benjamin Chun Yu ^b  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Chinese; CTLA 4; Genetic polymorphism; Ulcerative colitis

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MICROSATELLITE DNA; POLYACRYLAMIDE; SILVER;

3' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CHINA; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CTLA4 GENE; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; EXON; FEMALE; GENE; GENETIC POLYMORPHISM; HAPLOTYPE; HOMEOSTASIS; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SILVER STAINING; T LYMPHOCYTE ACTIVATION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLITIS, ULCERATIVE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33646817094     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000217339.61183.dd     Document Type: Article

References (39)

1. Xia B, Crusius JBA, Meuwissen SGM, et al. Inflammatory bowel disease: definition, epidemiology, etiology aspects, and immunogenetic studies. World J Gastroenterol. 1998;4:446-458.
2. Ahmad T, Tamboli CP, Jewell D, et al. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology. 2004;126:1533-1549.
3. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
5. Guo QS, Xia B, Jiang Y, et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol. 2004;10:1069-1071.
6. Leong RW, Armuzzi A, Ahmad T, et al. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003;17:1465-1470.
7. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002;47:469-472.
8. Mudter J, Neurath MF. Mucosal T cells: mediators or guardians of inflammatory bowel disease? Curr Opin Gastroenterol. 2003;19:343-349.
9. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 1998;280:243-248.
10. Walunas TL, Lenschow DJ, Bakker CY, et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994;1:405-413.
11. Dariavach P, Matte'i MG, Golstein P, et al. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol. 1988;18:1901-1905.
12. Harper K, Balzano C, Rouvier E, et al. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol. 1991;147:1037-1044.
13. Chistiakov DA, Turakulov RI. CTLA-4 and its role in autoimmune thyroid disease. J Molec Endocrinol. 2003;31:21-36.
14. Polymeropoulos MH, Xiao H, Rath DS, et al. Dinucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res. 1991;19:4018.
15. Huang D, Giscombe R, Zhou Y, et al. Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyperreactivity via the CD28 pathway in myasthenia gravis. J Neuroimmunol. 2000;105:69-77.
16. Wang XB, Zhao X, Giscombe R, et al. A CTLA-4 gene polymorphism at position -318 in the promotor region affects the expression of protein. Genes Immun. 2002;3:233-234.
17. Liger A, Teleshova N, Masteerman T, et al. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun. 2001;2:145-152.
18. Kouki T, Sawai Y, Gardine CA, et al. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol. 2000;165:6606-6611.
19. Munthe-Kaas CM, Carlsen KH, Helms PJ, et al. CTLA-4 polymorphisms in allergy and asthma and the Th1/Th2 paradigm. J Allergy Clin Immunol. 2004;114:280-287.
20. Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases: a general susceptibility gene to autoimmunity? Genes Immun. 2000;1:170-184.
21. Barmada MM, Brant SR, Nicolae DL, et al. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis. 2004;10:513-520.
22. van Heel DA, Fisher SA, Kirby A, et al. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet. 2004;1:763-770.
23. Xia B, Crusius JB, Wu J, et al. CTLA-4 gene polymorphisms in Dutch and Chinese patients with inflammatory bowel disease. Scand J Gastroenterol. 2002;37:1296-1300.
24. Hou W, Xia B, Yuan A, et al. CTLA-4 gene polymorphisms in Chinese patients with ulcerative colitis. Inflamm Bowel Dis. 2005;11:653-656.
25. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
26. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on therapeutic trial. Br J Med. 1955;2:1041-1048.
27. Huang DR, Liu L, Noren K, et al. Genetic association of CTLA-4 to myasthenia gravis with thymoma. J Neuroimmunol. 1998;88:192-198.
28. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97-98.
29. Rodriguez MR, Nunez-Roldan A, Aguilar F, et al. Association of the CTLA4 3′ untranslated region polymorphism with the susceptibility to rheumatoid arthritis. Hum Immunol. 2002;63:76-81.
30. Ahmed S, Ihara K, Kanemitsu S, et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford). 2001;40:662-667.
31. Zhou Y, Huang DR, Paris PL, et al. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum. 2004;50:2645-2650.
32. Wang XB, Kakoulidou M, Giscombe R, et al. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J Neuroimmunol. 2002;130:224-232.
33. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986;46:659-689.
34. Holopainen PM, Partanen JA. Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. J Immunol. 2001;167:2457-2458.
35. Torres B, Aguilar F, Franco E, et al. Association of the CT60 marker of the CTLA4 gene with systemic lupus erythmatosus. Arthritis Rheum. 2004;50:2211-2215.
36. Waterhouse P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with lethality in mice deficient in CTLA-4. Science. 1995;270:985-988.
37. Liu Z, Geboes K, Hellings P, et al. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J Immunol. 2001;167:1830-1838.
38. Makita S, Kanai T, Oshima S, et al. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol. 2004;173:3119-3130.
39. Sato T, Kanai T, Watanabe M, et al. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease. Gastroenterology. 2004;126:829-839.